Accueil>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>7-Methylguanosine 5’-diphosphate sodium

7-Methylguanosine 5’-diphosphate sodium (Synonyms: 7-Methyl-GDP sodium; m7GDP sodium)

Catalog No.GC62817

Le 7-méthylguanosine 5'-diphosphate (7-méthyl-GDP) sodium, un analogue de coiffe, peut être utilisé dans la synthèse d'analogues de coiffe d'ARNm.

Products are for research use only. Not for human use. We do not sell to patients.

7-Methylguanosine 5’-diphosphate sodium Chemical Structure

Cas No.: 104809-16-7

Taille Prix Stock Qté
1 mg
149,00 $US
En stock
5 mg
446,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

7-Methylguanosine 5’-diphosphate (7-Methyl-GDP) sodium, a cap analog, can be used in the synthesis of mRNA cap analogues[1].

7-Methylguanosine 5’-diphosphate sodium inhibits binding of eukaryotic initiation factors to reovirus capped mRNA and complex formation involving uncapped mRNA or 18 S rRNA[1].T. brucei mRNA decapping enzyme (TbDcp2) that cleaves 7-Methylguanosine 5’-diphosphate sodium from capped RNA to generate pRNA, a substrate for TbCe1[2].

[1]. Sonenberg N, et al. Nonspecific effect of m7GMP on protein-RNA interactions. J Biol Chem. 1978;253(19):6630-6632.
[2]. Ignatochkina AV, et al. The messenger RNA decapping and recapping pathway in Trypanosoma. Proc Natl Acad Sci U S A. 2015;112(22):6967-6972.

Avis

Review for 7-Methylguanosine 5’-diphosphate sodium

Average Rating: 5 ★★★★★ (Based on Reviews and 23 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 7-Methylguanosine 5’-diphosphate sodium

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.